Novanta (NOVT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
28 May, 2026Opening remarks and agenda
Chair welcomed attendees, introduced board members, executive team, and independent auditor present at the meeting.
Meeting called to order, agenda and rules of conduct made available on the virtual platform.
Board and executive committee updates
Board nominees for director positions were introduced, with terms expiring at the 2027 annual meeting.
Corporate governance
Scrutineer from Broadridge Financial Solutions appointed to oversee voting and quorum verification.
Quorum established with 93.7% of outstanding shares represented.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Novanta
- Q1 2026 revenue up 10.4%, bookings up 37%, and cash flow surged, with strong 2026 outlook.NOVT
Q1 202612 May 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on governance and ESG.NOVT
Proxy filing24 Apr 2026 - Record revenue, strong bookings, and 2026 guidance project further growth and margin expansion.NOVT
Q4 202510 Apr 2026 - Q2 revenue up 2.8% to $236M, with medical growth offsetting weak industrial demand.NOVT
Q2 20242 Feb 2026 - Q3 2024 revenue up 10.3% to $244.4M, with acquisitions driving growth and flat organic sales.NOVT
Q3 202416 Jan 2026 - 2024 saw record cash flow, margin gains, and new products; 2025 targets 5% growth amid volatility.NOVT
Q4 202411 Dec 2025 - Annual meeting covers director elections, say-on-pay, auditor appointment, and ESG oversight.NOVT
Proxy Filing1 Dec 2025 - Q1 2025 delivered revenue growth, higher net income, and resilient guidance amid trade risks.NOVT
Q1 202528 Nov 2025 - Q2 2025 revenue up 2.2%, strong bookings, but operating income down 42% on higher costs.NOVT
Q2 202523 Nov 2025